Studies have shown that the rate of NHL remains elevated at lower CD4 T-cell counts [44], potentially accounting for to the lack of decline in DLBCL in our cohort following the implementation of universal ART. The gene discussed is CD4; the disease is non-Hodgkin lymphoma.